Heart Failure Patients Demonstrate Impressive Improvement With Novel, Less ... MarketWatch (press release) SAN RAMON, CA, Apr 23, 2012 (MARKETWIRE via COMTEX) -- BioVentrix, the developer of minimally invasive therapies for the treatment of heart failure, will release this week the six-month results of a 26-patient trial demonstrating safety and feasibility ... |
